USPH (US Physical Therapy) Revenue: $795.5 Mil (TTM As of Mar. 2026)


USPH US Physical Therapy Inc USPH
78 GF Score
Price $72.54
GF Value $107.96
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is US Physical Therapy Revenue?

US Physical Therapy USPH -1.24% 78 Revenue is $795.5 Mil as of Mar. 2026. GuruFocus rates USPH with a GF Score™ of 78/100 and a GF Value™ of $107.96 (Significantly Undervalued). The stock has 6 warning signs investors should review.

US Physical Therapy's revenue for the three months ended in Mar. 2026 was $198.3 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2026 was $795.5 Mil. US Physical Therapy's Revenue per Share for the three months ended in Mar. 2026 was $13.07. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $52.39.

Good Sign:

US Physical Therapy Inc has shown predictable revenue and earnings growth.

During the past 12 months, the average Revenue per Share Growth Rate of US Physical Therapy was 13.10% per year. During the past 3 years, the average Revenue per Share Growth Rate was 6.50% per year. During the past 5 years, the average Revenue per Share Growth Rate was 8.00% per year. During the past 10 years, the average Revenue per Share Growth Rate was 5.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, US Physical Therapy's highest 3-Year average Revenue per Share Growth Rate was 181.80% per year. The lowest was 0.00% per year. And the median was 10.75% per year.


US Physical Therapy  (NYSE:USPH) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


US Physical Therapy Revenue Related Terms


US Physical Therapy Revenue Historical Data

* Premium members only.

The historical data trend for US Physical Therapy's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

US Physical Therapy Revenue Chart

US Physical Therapy Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 495.02 553.14 604.80 671.35 780.99

US Physical Therapy Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 183.79 197.34 197.13 202.73 198.29

USPH vs NUTX, PNTG, AMN: Revenue Comparison

For the Medical Care Facilities subindustry, US Physical Therapy's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


US Physical Therapy Revenue vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, US Physical Therapy's Revenue distribution charts can be found below:

* The bar in red indicates where US Physical Therapy's Revenue falls into.


USPH
78GF Score
US Physical Therapy Inc USPH
Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

US Physical Therapy Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $795.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of $795.5 Mil mean?
US Physical Therapy (USPH) has a Revenue of $795.5 Mil as of Mar. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on US Physical Therapy and its competitors.
Is US Physical Therapy's Revenue too high?
US Physical Therapy's current Revenue is $795.5 Mil. Overall, US Physical Therapy has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does US Physical Therapy's Revenue compare to NUTX and PNTG?
US Physical Therapy's Revenue of $795.5 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Healthcare Providers & Services company?
A good Revenue depends on the Healthcare Providers & Services industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on US Physical Therapy and its competitors. US Physical Therapy's current Revenue is $795.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is US Physical Therapy stock overvalued right now?
Based on GuruFocus' analysis, US Physical Therapy (USPH) is currently considered Significantly Undervalued. The stock's GF Value™ is $107.96, compared to a current price of $72.54 — trading 32.8% below its estimated fair value. The current Revenue is $795.5 Mil. US Physical Therapy's overall GF Score™ is 78/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For US Physical Therapy (USPH), the current Revenue is $795.5 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is US Physical Therapy (USPH) Overvalued in 2026?

Based on GuruFocus' analysis, US Physical Therapy stock appears to be undervalued. The current stock price of $72.54 is trading 32.8% below its estimated GF Value™ of $107.96. GuruFocus considers US Physical Therapy to be Significantly Undervalued.

Key valuation signals for USPH:

  • Revenue: $795.5 Mil
  • GF Value™: $107.96 vs. price of $72.54 (32.8% below fair value)
  • GF Score™: 78/100 with 6 warning signs

No single metric tells the full story. See the USPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


US Physical Therapy Business Description

Address 1300 West Sam Houston Parkway South, Suite 300, Houston, TX, USA, 77042
US Physical Therapy Inc through its subsidiaries operate outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
78GF Score

Get the complete analysis for USPH

Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$72.54
Price
$107.96
GF Value